Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
Titel:
Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
Auteur:
Hashimoto, Jun Garnero, Patrick Heijde, Désirée van der Miyasaka, Nobuyuki Yamamoto, Kazuhiko Kawai, Shinichi Takeuchi, Tsutomu Yoshikawa, Hideki Nishimoto, Norihiro